ZhouYZhangZLinS, et al.
Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions: a network meta-analysis of randomized controlled trials. J Endovasc Ther2020;
27: 42–59.
2.
BorensteinMHigginsJP.Meta-analysis and subgroups. Prev Sci2013;
14: 134–143.
3.
NakamuraSConroyRMGordonIL, et al.
A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. J Clin Ultrasound1995;
23: 461–471.
4.
VroegindeweijDTielbeekAVButhJ, et al.
Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. J Vasc Surg1995;
21: 255–268; discussion 268–269.
5.
WerkMLangnerSReinkensmeierB, et al.
Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;
118: 1358–1365.
6.
ScheinertDSchulteKLZellerT, et al.
Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial. J Endovasc Ther2015;
22: 14–21.
